Saturday 17 October 2026
Export OFIX’s income statement to Excel — free account
ORTHOFIX MEDICAL INC.
OFIX Healthcare Medical Devices
ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024. In the quarter to June 2026, revenue grew 3.85%, EPS fell 8.33%, free cash flow fell 516.6% and total debt rose 34.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
9.38
0.21
−2.19%
Follow OFIX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 330.62 | 0.00 | 71.90 | 160.41 | 209.00 |
Piotroski F-Score |
5 | 5 | 2 | 4 | 5 | 4 | 3 | 6 | 8 | 8 |
P/S ratio |
0.73 | 0.83 | 0.65 | 0.93 | 1.32 | 2.04 | 1.90 | 2.14 | 2.28 | 1.57 |
Altman Z-Score |
1.29 | 1.53 | 1.32 | 3.39 | 4.02 | 4.21 | 4.51 | 6.29 | 7.62 | 5.51 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.14 | 87.45 | 30.77 | 52.44 | 16.60 |
Altman Z″-Score (non-manufacturers) |
1.02 | 1.65 | 2.20 | 5.18 | 4.81 | 4.58 | 4.50 | 5.96 | 6.90 | 5.45 |
Beneish M-Score |
(3.19) | (3.35) | (2.49) | (2.43) | (3.06) | (3.28) | (3.04) | (2.45) | (2.81) | (3.23) |
P/Operating CF |
21.68 | 28.06 | (72.04) | 182.35 | 51.97 | 37.15 | 73.09 | 46.03 | 33.11 | 31.17 |
P/B ratio |
1.33 | 1.32 | 0.81 | 1.27 | 1.82 | 2.32 | 2.66 | 2.89 | 3.33 | 2.45 |
Price to Tangible BV |
3.29 | 3.18 | 1.68 | 1.96 | 2.87 | 3.90 | 4.31 | 4.60 | 4.25 | 3.18 |
EV/Sales |
0.85 | 0.95 | 0.75 | 0.87 | 1.18 | 1.86 | 1.79 | 2.03 | 2.14 | 1.49 |
EV/EBITDA |
380.93 | 215.57 | 0.00 | 21.21 | 15.02 | 27.00 | 85.15 | 18.45 | 14.80 | 14.05 |
EV/Operating CF |
20.87 | 29.51 | (12.18) | (34.58) | 29.70 | 10.18 | 25.77 | 18.40 | 23.78 | 10.34 |
EV/FCF |
(193.86) | (66.79) | (5.06) | (10.83) | (187.64) | 15.65 | 82.69 | 29.11 | 49.20 | 15.72 |
Quick Ratio |
1.30 | 1.31 | 1.00 | 1.60 | 1.57 | 1.63 | 1.85 | 1.75 | 1.82 | 1.34 |
Current Ratio |
2.45 | 2.57 | 2.54 | 3.06 | 2.55 | 2.60 | 3.07 | 2.85 | 3.17 | 2.33 |
Net Debt/EBITDA |
48.90 | 25.24 | (1.77) | (1.55) | (1.74) | (2.57) | (4.91) | (1.45) | (1.30) | (1.24) |
Debt/Assets |
20.51% | 19.57% | 12.20% | 4.69% | 5.10% | 4.74% | 4.61% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.39 | 0.35 | 0.19 | 0.06 | 0.07 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.94 | 0.88 | 1.08 | 0.99 | 0.93 | 0.80 | 0.96 | 1.04 | 1.12 | 1.06 |
Operating CF/Net income |
(0.36) | (0.20) | 0.30 | 0.58 | (0.48) | 29.51 | (1.13) | 3.61 | 6.26 | 19.33 |
Capex/Depreciation |
(0.42) | (0.40) | (0.64) | (0.72) | (0.44) | (0.71) | (0.72) | (0.85) | (0.75) | (0.82) |
Interest Coverage |
(4.66) | (2.86) | (16.12) | (10.30) | (4.53) | (2.52) | (153.97) | 36.35 | 98.10 | (27.61) |
| (19.34%) | (22.87%) | (32.36%) | (5.86%) | (11.06%) | 0.74% | (8.59%) | 4.37% | 2.22% | 1.10% | |
| (10.57%) | (13.86%) | (21.88%) | (4.22%) | (7.66%) | 0.49% | (5.92%) | 3.17% | 1.60% | 0.79% | |
ROIC |
(9.44%) | (8.93%) | (12.90%) | (2.70%) | (1.90%) | (1.37%) | (4.19%) | 7.15% | 11.84% | 6.28% |
Return on Tangible Assets |
(24.53%) | (31.15%) | (36.54%) | (8.56%) | (17.21%) | 1.09% | (11.94%) | 6.85% | 2.86% | 1.91% |
Average Days of Receivables |
60.25 | 61.50 | 62.62 | 65.64 | 61.73 | 65.02 | 68.88 | 62.64 | 53.37 | 51.53 |
Research and Development Expense of Revenue |
8.01% | 9.21% | 10.75% | 10.65% | 10.68% | 9.61% | 7.53% | 7.33% | 6.85% | 7.03% |
Selling, General and Administrative Expense of Revenue |
67.41% | 66.61% | 71.04% | 67.02% | 62.58% | 67.00% | 67.24% | 63.74% | 62.30% | 62.89% |
Intangible Assets out of Total Assets |
0.31 | 0.33 | 0.34 | 0.26 | 0.26 | 0.27 | 0.25 | 0.27 | 0.16 | 0.16 |
Share Based Compensation of Revenue |
3.49% | 4.06% | 4.78% | 4.00% | 3.32% | 3.99% | 4.68% | 4.18% | 2.89% | 3.90% |
Graham Net Nets |
0.03 | 0.06 | 0.19 | 0.31 | 0.21 | 0.12 | 0.11 | 0.12 | 0.14 | 0.13 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.36 | 0.00 | 17.26 | 11.19 | 7.45 |
Earnings Yield |
(15.44%) | (18.84%) | (31.53%) | (4.59%) | (6.24%) | 0.30% | (3.27%) | 1.39% | 0.62% | 0.48% |
Free Cash Flow Yield |
(0.60%) | (1.71%) | (22.84%) | (8.60%) | (0.48%) | 5.84% | 1.14% | 3.25% | 1.91% | 6.02% |
Revenue per Share |
20.76 | 20.97 | 20.33 | 22.97 | 23.59 | 21.10 | 24.33 | 24.50 | 23.95 | 22.59 |
Operating CF per Share |
0.84 | 0.68 | (1.25) | (0.58) | 0.94 | 3.85 | 1.69 | 2.70 | 2.15 | 3.26 |
Capex per Share |
(0.87) | (0.91) | (1.69) | (1.15) | (0.99) | (1.26) | (1.09) | (0.90) | (0.91) | (1.01) |
Free Cash Flow per Share |
(0.03) | (0.24) | (2.94) | (1.73) | (0.06) | 2.59 | 0.61 | 1.80 | 1.24 | 2.25 |
Cash per Share |
2.15 | 2.25 | 1.03 | 2.53 | 4.46 | 5.03 | 3.72 | 3.90 | 4.48 | 2.97 |
Shareholders Equity per Share |
11.36 | 13.19 | 16.30 | 16.80 | 17.11 | 18.52 | 17.33 | 18.14 | 16.37 | 14.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.36 | 13.19 | 16.30 | 16.80 | 17.11 | 18.52 | 17.33 | 18.14 | 16.37 | 14.52 |
Free Cash Flow |
(1.28) | (9.09) | (107.80) | (34.70) | (1.12) | 49.94 | 11.51 | 33.21 | 22.50 | 40.74 |
Working Capital |
246.37 | 264.66 | 255.22 | 172.37 | 163.69 | 166.48 | 175.67 | 158.73 | 172.40 | 110.93 |
Capital Expenditures |
(34.63) | (34.88) | (62.05) | (23.16) | (19.59) | (24.33) | (20.52) | (16.70) | (16.47) | (18.33) |
Net Current Asset Value |
16.24 | 43.12 | 93.86 | 134.22 | 129.83 | 101.38 | 92.56 | 113.40 | 143.06 | 85.75 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.52 | 22.71 | 28.99 |
Capex to Sales |
0.04 | 0.04 | 0.08 | 0.05 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.26 | 24.21 | 30.60 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.64 | 0.63 | 0.61 | 0.55 | 0.76 | 0.54 | 0.45 | 0.46 | 0.48 | 0.46 |
Cash ROIC |
(0.18%) | (1.19%) | (14.39%) | (8.48%) | (0.25%) | 10.43% | 2.73% | 8.15% | 5.96% | 12.84% |
Accounts Receivable Turnover |
6.08 | 6.08 | 7.08 | 5.71 | 6.15 | 5.11 | 5.59 | 6.42 | 7.15 | 6.96 |
Accounts Payable Turnover |
4.78 | 4.73 | 6.06 | 4.57 | 4.64 | 4.74 | 5.31 | 5.35 | 5.73 | 5.72 |
Inventory Turnover |
1.42 | 1.23 | 1.62 | 1.35 | 1.37 | 1.22 | 1.26 | 1.22 | 1.29 | 1.45 |
Average Days of Payables |
83.16 | 70.24 | 81.81 | 81.54 | 84.04 | 82.82 | 72.15 | 67.95 | 71.05 | 59.63 |
Days of Inventory on Hand |
245.41 | 272.67 | 311.45 | 295.88 | 263.55 | 303.19 | 298.93 | 290.28 | 319.07 | 263.18 |
Average Receivables |
135.23 | 131.41 | 105.48 | 80.71 | 75.49 | 79.61 | 82.28 | 70.59 | 60.64 | 58.84 |
Average Payables |
53.60 | 53.58 | 42.98 | 27.03 | 24.79 | 21.50 | 18.94 | 18.05 | 16.23 | 15.37 |
Average Inventory |
180.89 | 205.81 | 161.16 | 91.56 | 83.80 | 83.52 | 79.62 | 79.09 | 72.34 | 60.45 |
Average Assets |
871.97 | 909.30 | 691.97 | 467.63 | 501.24 | 510.74 | 481.13 | 436.00 | 388.73 | 386.16 |
Average Common Equity |
476.58 | 550.93 | 467.80 | 336.90 | 346.90 | 342.25 | 331.51 | 316.00 | 280.04 | 276.89 |
Columns are period end dates